Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
CHARM Therapeutics
start up
United Kingdom
- London
- 09/06/2022
- Series A
- $50,000,000
Harnessing the power of deep learning on 3D molecular configurations to deliver medicines of transformational efficacy to patients.
- Industry Research Services
- Website https://charmtx.com/
- LinkedIn https://www.linkedin.com/company/charm-therapeutics/
Related People
Laksh AithaniFounder
United Kingdom -
London, England,
Passionate about drug discovery and machine learning
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)